Dr Karriem H Ali MD
Dr. Karriem H. Ali, M.D. is the CSO of iPraxic.org, a foundation focused on Natural Product Immunotherapy and Longevity research and education. He holds degrees from Harvard (Chemistry, Organic-Medicinal), and Stanford (M.D.), earning Distinguished University Honors in Research as a Stanford-NIH Cancer Biology Fellow, and AHA Critical Cardiology-Immunology Research Fellow.
2008 - Strategic Immunotherapy in the Treatment and Prevention of Ageing-related Diseases & Disorders - Coronary Heart Disease, Metabolic Syndrome & Non Insulin-Dependent Diabetes Mellitus, Cancer
Fundamentally, humankind has long thought of aging as a gradual decline in one’s well-being and quality of life, with an increased incidence and severity of debilitating chronic diseases. However, the present basic and medical science argues for a fresh and more enlightened perspective. Here, we present an evidence-based synthesis gleaned from our existent and ongoing laboratory and clinical research findings along with the existent knowledge in the field, to propose that:
- Aging is a multifactorial clinical syndrome primarily resulting from progressive “Immunosenescence”—
- Immunosenescence is an insidious process—typically of early onset and advancing with age in adulthood—which leads to autoimmune disorders and impaired immune responses to antigen exposure;
- Immunosenescence also appears to be directly associated with the phenomenon of age-related telomere shortening, which is known to reduce cellular proliferative capacity in the immune system;
- The use of Allotypic Immunomodulators (AIMs) to achieve a persistent reversal of immunosenescence may well be the simplest common denominator available for solving the healthful longevity equation;
- The Strategic Immunotherapy approach suggests a novel and effective paradigm in the amelioration and treatment of aging and its related diseases & disorders
Goals & Objectives
To familiarize attendees with:
- An understanding of Immunosenescence as a process which can produce a clinical picture consistent with what is accepted as Aging;
- An understanding of prevalent factors in our patients and society as a whole —i.e., environment, dietary, lifestyle—that support the consideration of Immune Dysfunction as sufficiently ubiquitous to play a key causal role in Aging;
- The Strategic Immunotherapy approach;
- Clinical strategies in several diseases and disorders of aging, e.g. Coronary Heart Disease, Cancer, Metabolic Syndrome & NIDDM.